Healthtech Firm Accolade Is Buying Telemedicine Startup 2nd.MD for $460 Million

Accolade has agreed to acquire telemedicine startup 2nd.MD to improve its ability to provide users with second opinions, reports CNBC News . Accolade is reportedly spending around $460 million on its buyout of 2nd.MD parent Innovation Specialists. The takeover is said to nearly double Accolade's addressable market to about $46 billion by adding a provider of expert medical opinions from a network of U.S. doctors to its stable. 2nd.MD automates the process of getting second opinions so they occur within days over video or phone. "2nd.MD will take your medical records and provide them to a network of physicians who specialize in those disease categories, and those physicians will do a video consultation to give you another opinion about what the right next step is," said Accolade CEO Raj Singh.